Nuclear phenotypes and morphometry of human secretory prostate cells: A comparative study of benign and malignant lesions in Brazilian patients

Caryologia

Volumn 56, Issue 3, 2003, Pages 315-322

  Taboga, Sebastião R ^a,b   Santos, Adriana B Dos ^c   Gonzatti, Adriana G R ^a   Vidal, Benedicto C ^a   Mello, Maria Luiza S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b 2265 Jardim Nazareth ^*  (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Benign lesions; Brazilian patients; Human prostate; Malignant lesions; Nuclear morphometry

Indexed keywords

EID: 77949752594     PISSN: 00087114     EISSN: 21655391     Source Type: Journal    
DOI: 10.1080/00087114.2003.10589340     Document Type: Article

References (24)

1. Alcaraz A., Barranco M.A., Corral J.M, Ribal M.J., Carrio A., Mallofre C., Llopis J., Ceti-na A. and Alvarez-Vijande R., 2001 High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer. Prostate, 47: 29-35.
2. Bartels P.H., da Silva V.D., Montironi R., Hamilton P.W., Thompson D. and Bartels H.G., 1998c Chromatin texture signatures in nuclei from prostate lesions. Anal. Quant. Cytol. Histol., 20:407-416.
3. Bartels PH., Montironi R., Hamilton P.W., Thompson D., Vaugth L. and Bartels H.G., 1998a Nuclear chromatin texture in prostatic lesions. I. PIN and adenocarcinoma. Anal. Quant. Cytol. Histol., 20: 389-396.
4. Bartels PH., Montironi R., Hamilton P.W., Thompson D., Vaugth L. and Bartels H.G., 1998b Nuclear chromatin texture in prostatic lesions. II. PIN and malignancy associated changes. Anal. Quant. Cytol. Histol., 20: 397-406.
5. Bartels PH., Montironi R.M., Bostwick D., Marshall J., Thompson D., Bartels H.G. and Kelly D., 2001 Karyometry of secretory cell nuclei in high-grade PIN lesions. Prostate, 48: 144-155.
6. Beil M., Irinopoulou T. and Rigaut J.P, 1996 Application of confocal scanning laser microscopy for an automated nuclear grading of prostate lesions in three dimensions. J. Microsc., 183: 231-240.
7. Choi N.G., Sohn J.H., Park H.W. and Jung T.Y., 1999 Apoptosis and nuclear shapes in benign prostate hyperplasia and prostate adenocarcinoma: comparison with and relation to Gleason score. Int. J. Urol., 6: 13-18.
8. Clinton S.K., Mulloy A.L., Li S.P., Mangian H.J. and Vlsek W.J., 1997 Dietary fat and protein intake differ in modulation of prostate tumor growth, prolactin secretion and metabolism, and prostate gland prolactin binding capacity in rats. J. Nutr., 127: 225-237.
9. Denis L., Morton M.S. and Griffiths K., 1999 Diet and its preventive role in prostatic disease. Eur.J. Urol., 35: 377-387.
10. Gleason D.F., 1977 Histologic grading and clinical staging of prostatic carcinoma. In: Lea and Febiger (eds.), “Urologic Pathology: the Prostate”, pp. 171-197, Philadelphia.
11. Kiehl R., Correa E.T., VENęo F.E. and Ortiz V., 2000 Analysis of DNA ploidy heterogeneity in prostate cancer. Braz. J. Urol., 26: 29-31.
12. Landstrom M., Zhang J.X., Hallmans G., Aman P., Bergh A., Damber J.E., Mazur W., Waha-la K. and Adlercreutz H., 1998 Inhibitory effects of soy and rye diets on the development of Dunning R3327prostate adenocarcinoma in rats. Prostate, 36: 151-161.
13. Lopez-Beltran A., Artacho-Perula E., Luque-Barona R.J. and Roldan-Villalobos R., 2000 Nuclear estimates in prostatic atypical adenomatous hyperplasia. Anal. Quant. Cytol. Histol., 22: 438-444.
14. Mohler J.L., Partin A.W., Epstein J.I., Lohr W.D. and Coffey D.S., 1988 Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. 2. Standardization of methodology for histologic sections.]. Urol., 139: 1085-1090.
15. Mohler J.L., Partin A.W., Lohr W.D. and Coffey D.S., 1988 Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. 1. Testing of a digitalization system.]. Urol., 139: 1080-1084.
16. Montironi R., Bartels PH. and Bostwick D.G., 1998 Quantitative methods in prostate pathology Recent findings and future directions -Introduction. Anal. Quant. Cytol. Histol., 20: 321.
17. Montironi R., Thompson D., Scarpelli M., Bartels H.G., Hamilton P.W., da Silva V.D., Sakr W.A., Weyn B., Van A. Daele and Bartels PH., 2002 Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia.]. Clin. Pathol., 55: 452-460.
18. Morton M.S., Chan P.S.F., Cheng C., Blacklock N., Matos Ferreira A., Abranches Monteiro L., Correia R., Lloyd S. and Griffiths K., 1997 Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate, 32: 122-128.
19. Noether G.E., 1976 Introduction to Statistics: a Nonparametric Approach, Houghton Miffing Co. 2 25p.
20. Petein M., Decaestecker C., Segers V., Janssen T., Fourmarier M., VanLeer P., van Velthoven R., Schulman C., Pasteels J.L. and Kiss R., 1996 Does any correlation exist between the Gleason classification system and the computer-assisted microscope analysis ofFeul-gen-stained nuclei features in human prostate adenocarcinoma? Anal. Cell. Path., 12: 159-171.
21. Taboga S.R., 1999 Apoptosis as a mediator of hyperplastic recovery on human prostate: cyto-chemical and immunocytochemical evaluation. Cytobios, 99: 19-26.
22. Tucci S., Blumenfeld W. and Narayan P., 1994 Ploidy status correlates with outcome in stage B prostate adenocarcinoma. Braz. J. Med. Biol. Res., 27: 25-32.
23. Vanderpoel H.G., Mulders P.F.A., Aalders T.W., Oosterhof G.O.N., Debruyne F.M.J. and Schalken J.A., 1994 Karyometric analysis of intratumor heterogeneity in prostate adenocarcinoma. Anal. Cell. Path., 7: 153-170.
24. Wang N., Stenkvist B.G. and Tribukait B., 1992 Morphometry of nuclei of normal and malignant prostate in relation to DNA ploidy. Anal. Quant. Cytol. Histol., 14: 210-216.